Brief: Spago Nanomedical Q1 Sales SEK 338 Thousand
May 07 (Reuters) - Spago Nanomedical Q1 operating expenses SEK -8.964 million. Q1 adjusted EPS SEK -0.02 Q1 net income SEK -7.435 million
May 07 (Reuters) - Spago Nanomedical Q1 operating expenses SEK -8.964 million. Q1 adjusted EPS SEK -0.02 Q1 net income SEK -7.435 million